358 related articles for article (PubMed ID: 27078619)
1. Persistent HIV-1 replication during antiretroviral therapy.
Martinez-Picado J; Deeks SG
Curr Opin HIV AIDS; 2016 Jul; 11(4):417-23. PubMed ID: 27078619
[TBL] [Abstract][Full Text] [Related]
2. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
[TBL] [Abstract][Full Text] [Related]
3. Review: Influence of ART on HIV genetics.
Simonetti FR; Kearney MF
Curr Opin HIV AIDS; 2015 Jan; 10(1):49-54. PubMed ID: 25389802
[TBL] [Abstract][Full Text] [Related]
4. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
5. Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.
Chaillon A; Gianella S; Lada SM; Perez-Santiago J; Jordan P; Ignacio C; Karris M; Richman DD; Mehta SR; Little SJ; Wertheim JO; Smith DM
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142136
[TBL] [Abstract][Full Text] [Related]
6. Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
Alatrakchi N; Duvivier C; Costagliola D; Samri A; Marcelin AG; Kamkamidze G; Astriti M; Agher R; Calvez V; Autran B; Katlama C
AIDS; 2005 Jan; 19(1):25-33. PubMed ID: 15627030
[TBL] [Abstract][Full Text] [Related]
7. Review: HIV-1 phylogeny during suppressive antiretroviral therapy.
Bale MJ; Kearney MF
Curr Opin HIV AIDS; 2019 May; 14(3):188-193. PubMed ID: 30882485
[TBL] [Abstract][Full Text] [Related]
8. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
9. Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.
Cadena AM; Ventura JD; Abbink P; Borducchi EN; Tuyishime H; Mercado NB; Walker-Sperling V; Siamatu M; Liu PT; Chandrashekar A; Nkolola JP; McMahan K; Kordana N; Hamza V; Bondzie EA; Fray E; Kumar M; Fischinger S; Shin SA; Lewis MG; Siliciano RF; Alter G; Barouch DH
Nat Commun; 2021 Mar; 12(1):1474. PubMed ID: 33674572
[TBL] [Abstract][Full Text] [Related]
10. Residual Viremia in Treated HIV+ Individuals.
Conway JM; Perelson AS
PLoS Comput Biol; 2016 Jan; 12(1):e1004677. PubMed ID: 26735135
[TBL] [Abstract][Full Text] [Related]
11. Harnessing CD8
Warren JA; Clutton G; Goonetilleke N
Front Immunol; 2019; 10():291. PubMed ID: 30863403
[TBL] [Abstract][Full Text] [Related]
12. No evidence of HIV replication in children on antiretroviral therapy.
Van Zyl GU; Katusiime MG; Wiegand A; McManus WR; Bale MJ; Halvas EK; Luke B; Boltz VF; Spindler J; Laughton B; Engelbrecht S; Coffin JM; Cotton MF; Shao W; Mellors JW; Kearney MF
J Clin Invest; 2017 Oct; 127(10):3827-3834. PubMed ID: 28891813
[TBL] [Abstract][Full Text] [Related]
13. Establishment and stability of the latent HIV-1 DNA reservoir.
Brodin J; Zanini F; Thebo L; Lanz C; Bratt G; Neher RA; Albert J
Elife; 2016 Nov; 5():. PubMed ID: 27855060
[TBL] [Abstract][Full Text] [Related]
14. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 Reservoirs During Suppressive Therapy.
Barton K; Winckelmann A; Palmer S
Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal sequencing of HIV-1 infected patients with low-level viremia for years while on ART shows no indications for genetic evolution of the virus.
Vancoillie L; Hebberecht L; Dauwe K; Demecheleer E; Dinakis S; Vaneechoutte D; Mortier V; Verhofstede C
Virology; 2017 Oct; 510():185-193. PubMed ID: 28750322
[TBL] [Abstract][Full Text] [Related]
17. Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.
Mullins JI; Frenkel LM
J Infect Dis; 2017 Mar; 215(suppl_3):S119-S127. PubMed ID: 28520966
[TBL] [Abstract][Full Text] [Related]
18. Differences in HIV Markers between Infected Individuals Treated with Different ART Regimens: Implications for the Persistence of Viral Reservoirs.
Darcis G; Berkhout B; Pasternak AO
Viruses; 2020 Apr; 12(5):. PubMed ID: 32349381
[TBL] [Abstract][Full Text] [Related]
19. Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy.
Giron LB; Tenore SB; Janini LMR; Sucupira MCA; Diaz RS
PLoS One; 2019; 14(6):e0217502. PubMed ID: 31206536
[TBL] [Abstract][Full Text] [Related]
20. Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.
Rose R; Nolan DJ; Maidji E; Stoddart CA; Singer EJ; Lamers SL; McGrath MS
AIDS Res Hum Retroviruses; 2018 Jan; 34(1):3-8. PubMed ID: 28691499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
